Observational studyResuscitation2026
External validation of rules for termination of resuscitation in in-hospital cardiac arrest.
Observational study in Resuscitation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Trends and variation in use of end-tidal carbon dioxide during in-hospital cardiac arrest: an observational cohort study.Frontiers in medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
importanceTermination of resuscitation rules aim to avoid prolonged, futile resuscitative efforts, reducing patient and provider burden. To date, however, no widely adopted rule exists for termination of in-hospital cardiac arrest. A recent study derived a termination rule (unwitnessed, unmonitored, asystole, and no return of spontaneous circulation within 10 min) in a Scandinavian cohort with an acceptably high positive rate for clinical utility and a very low rate of patients meeting the rule who survived to 30-days.
objectiveTo externally validate previously derived termination of resuscitation rules for patients suffering in-hospital cardiac arrest.
designObservational study of a prospectively collected in-hospital cardiac arrest cohort including years 2012-2024.
settingParticipating hospitals from the American Heart Association Get With The Guidelines-Resuscitation registry.
participantsAdult patients (≥18 years) who suffered in-hospital cardiac arrest. EXPOSURE: Meeting a previously described termination of resuscitation rule. MAIN OUTCOME: Survival to hospital discharge. Positive rates, false positive rates, false discovery rates, and resuscitation time potentially avoided were calculated. Hypothesis formulated prior to analysis.
resultsOf 646,794 patients, 359,686 met inclusion criteria across 703 hospitals. Overall survival to discharge was 23.1%. For the primary Scandinavian termination Rule 1, the positive rate (patients meeting Rule criteria) was 1.7%; 32.9% of whom achieved return of spontaneous circulation and 5.1% survived to discharge. Median resuscitation time potentially avoided was 11 min per patient meeting Rule 1 criteria, equating to ∼18 min per 100 events. Across hospitals, positive rates ranged from 0% to 11.9. Other termination rules demonstrated either very low average positive rates (<3%) or unacceptably high survival rates among patients meeting the rule. Findings were similar in sensitivity analyses excluding the COVID-19 era.
conclusionsIn this large American cohort, previously derived termination rules for in-hospital cardiac arrest demonstrated either limited applicability or unacceptable error rates. Even the best-performing Scandinavian rule identified few patients for early termination and would have led to premature cessation in ∼5% of survivors. These findings underscore the need for further refinement of termination rules before clinical adoption in the United States.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.